Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV)
US takes next step in Medicare drug price negotiations with pharma companies
US takes next step in Medicare drug price negotiations with pharma companies
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript
Roivant's anti-inflammatory drug succeeds in mid-stage study
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
This Biopharma Stock Outperforms MSTR and SMCI in March 2024
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.